David C. Olson
President chez aLight Sciences, Inc.
Postes actifs de David C. Olson
| Sociétés | Poste | Début |
|---|---|---|
| University of Michigan | Corporate Officer/Principal | 28/04/2011 |
aLight Sciences, Inc.
 aLight Sciences, Inc. Medical SpecialtiesHealth Technology aLight Sciences, Inc. specializes in developing techniques and strategies for molecule detection in protein analytics. The company is based in Ann Arbor, MI. | President | - |
Anciens postes connus de David C. Olson
| Sociétés | Poste | Fin |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Fondateur | - |
Swift Biosciences, Inc.
 Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Fondateur | - |
Accuri Cytometers, Inc.
 Accuri Cytometers, Inc. Medical SpecialtiesHealth Technology Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI. | Directeur Technique/Scientifique/R&D | - |
PanCel Corp.
 PanCel Corp. Medical/Nursing ServicesHealth Services PanCel Corp. develops technology to genetically engineer pancreatic cell lines for the cure of diabetes. Its product under development is a bio-artificial endocrine pancreas that can be safely transplanted into diabetic patients to restore normal glucose-responsive insulin secretion with no or minimal immunosuppressive drugs. The company was founded in 1998 and is headquartered in Del Mar, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de David C. Olson
| Princeton University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Accuri Cytometers, Inc.
Accuri Cytometers, Inc. Medical SpecialtiesHealth Technology Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI. | Health Technology |
PanCel Corp.
PanCel Corp. Medical/Nursing ServicesHealth Services PanCel Corp. develops technology to genetically engineer pancreatic cell lines for the cure of diabetes. Its product under development is a bio-artificial endocrine pancreas that can be safely transplanted into diabetic patients to restore normal glucose-responsive insulin secretion with no or minimal immunosuppressive drugs. The company was founded in 1998 and is headquartered in Del Mar, CA. | Health Services |
aLight Sciences, Inc.
aLight Sciences, Inc. Medical SpecialtiesHealth Technology aLight Sciences, Inc. specializes in developing techniques and strategies for molecule detection in protein analytics. The company is based in Ann Arbor, MI. | Health Technology |
Swift Biosciences, Inc.
Swift Biosciences, Inc. BiotechnologyHealth Technology Swift Biosciences, Inc. develops molecular biology reagents. It offers Next Generation Sequencing sample preparation for Illumina and Ion Torrent platforms. The firm?s products include Accel-NGS and Amplicon Panels and myT Primer. The company was founded by David C. Olson and Vladimir L. Makarov in February 2010 and is headquartered in Ann Arbor, MI. | Health Technology |
